Organogenesis Holdings (ORGO) Asset Writedowns and Impairment (2018 - 2024)

Organogenesis Holdings' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $18.8 million for Q2 2024.

• In Q2 2024, Asset Writedowns and Impairment changed N/A year-over-year to $18.8 million; the TTM figure through Dec 2024 stood at $18.8 million (up 15544.26% YoY), while the FY2024 annual figure was $18.8 million, changed N/A from the prior year.
• Asset Writedowns and Impairment was $18.8 million for Q2 2024 at Organogenesis Holdings, up from -$855000.0 in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $18.8 million in Q2 2024 to a low of -$1.4 million in Q4 2020.
• Historically, Asset Writedowns and Impairment has averaged $1.8 million across 4 years, with a median of $632000.0 in 2021.
• Biggest YoY gain for Asset Writedowns and Impairment was 2937.5% in 2020; the steepest drop was 613.43% in 2020.
• A 4-year view of Asset Writedowns and Impairment shows it stood at -$1.4 million in 2020, then surged by 145.93% to $632000.0 in 2021, then plunged by 235.28% to -$855000.0 in 2022, then surged by 2303.74% to $18.8 million in 2024.
• The last three Asset Writedowns and Impairment figures came in at $18.8 million (Q2 2024), -$855000.0 (Q4 2022), and $733000.0 (Q3 2022), per Business Quant data.